Medindia

X

BIO-key(R) International & Healthcare-ID to Showcase Biometric ID Technology at 56th Annual California Blood Bank Society Meeting

Wednesday, April 21, 2010 General News J E 4
Advertisement


WALL, N.J., April 21 BIO-key International, Inc. (OTC Bulletin Board: BKYI), a leader in finger-based biometric identification solutions, today announced that BIO-key and its partner, Healthcare-ID, a leader in automated donor management solutions, will jointly participate at the 56th Annual Meeting of the California Blood Bank Society in BOOTH #123.

(Logo: http://www.newscom.com/cgi-bin/prnh/20050509/BIOKEYLOGO)

The CBBS Annual Meeting, being held on April 21-24, 2010, at the Hyatt Regency in Orange County, is recognized as the premier State association meeting, attracting physicians, medical technologists, nurses, product managers, donor resource professionals, and administrators from all over the western United States.

BIO-key's fingerprint biometric software, the preferred identification technology selected by blood centers across the US and was recognized by SC Magazine as the 2009 Industry Innovator in Biometrics, is now integrated into Healthcare-ID's donor management software platform, Donor-ID Web(TM). At the CABB 56th annual meeting, BIO-key and Healthcare-ID will demonstrate a wide spectrum of their state-of-the-art solutions. These solutions leverage the superior accuracy and scalability of the BIO-key biometric identity software.

"BIO-key's flexible and easy to implement identification solutions are the ideal choice for every blood collection agency. With the recent launch of our fully hosted TruDonor(TM) Blood Center Identity Solution we now offer a full suite of donor ID solutions that can be quickly integrated into existing applications or run as a standalone application," said Mike DePasquale, president and CEO of BIO-key International.

He continued, "Our fingerprint biometric identity solutions reduce the risks associated with misidentifying donors while providing the donors with a more convenient way to establish their identity."

Bryan Sadorf, vice president, Healthcare-ID, Inc., noted that, "At HID we are pleased to offer BIO-key's proven level of scalability and accuracy in identification to the donor environment. We see a long-term cost and safety advantage to our customers through this partnership. BIO-key is unique in the marketplace in that it performs high-speed identification searches against hundreds of thousands or millions of donor records, not simply verifications, so the entire donor check-in process is streamlined as a result."

Of note, is that Donor-ID Web(TM) is used to collect over 7,000,000 units of blood annually at eleven blood centers across the United States: Gulf Coast Regional Blood Center in Houston, TX; Memorial Blood Center in St Paul, MN; Mississippi Blood Services in Jackson, MS; Oklahoma Blood Institute in Oklahoma City, OK; Coffee Memorial Blood Center in Amarillo, TX; Blood Bank of Delmarva in Newark, DE; Stanford Blood Center in Palo Alto, CA, LifeStream in San Bernardino, CA, ITxM in Illinois (LifeSource Blood Services), Pennsylvania, and West Virginia (Central Blood Bank), and The American Red Cross, nationwide. Seven customers are using SafeTrace as their data management system. Healthcare-ID also has customers using BBCS, LifeTec, and NBCS.

About BIO-key

BIO-key International, Inc., headquartered in Wall, New Jersey, develops and delivers advanced identification solutions to commercial and government enterprises, integrators, and custom application developers. BIO-key's award winning, high performance, scalable, cost-effective and easy-to-deploy biometric finger identification technology accurately identifies and authenticates users of wireless and enterprise applications. Our solutions are used in local embedded OEM products as well as some of the world's largest identification deployments to improve security, guarantee identity, and help reduce identity theft. BIO-key's technology is offered directly or by market leading partners around the world. (http://www.bio-key.com)

About Healthcare-ID

Incorporated in January 1995, Healthcare-ID develops and markets products to meet the Blood Center's need for automating the entry of accurate information at both fixed and mobile collection sites to eliminate disposal of collected blood units based on donor eligibility and suitability and significantly reduce the cost of blood collection. Healthcare-ID, with its Donor-ID Web product offers modules including Registration, Health History Screening, CASI, iCASI, Physical Exam, Daily QC, Phlebotomy, Shipping, Survey, and Donor Reaction (as developed with the AABB Biovigilance committee) Donor-ID Web interfaces to most major blood center data management systems. (http://www.healthcare-id.com)

BIO-key Safe Harbor Statement

Certain statements contained in this press release may be construed as "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act. These statements are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected on the basis of these statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue, our ability to develop new products and evolve existing ones, the impact on our business of the recent financial crisis in the global capital markets and negative global economic trends, and our ability to attract and retain key personnel. For a more complete description of these and other risk factors that may affect the future performance of BIO-key International, Inc., see "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2008 and its other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. The Company also undertakes no obligation to disclose any revision to these forward-looking statements to reflect events or circumstances after the date made or to reflect the occurrence of unanticipated events.

SOURCE BIO-key International, Inc.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Medifast, Inc. to Announce Results for the First Q...
S
Capital BlueCross Offers Continued Coverage For Yo...